Pfizer, U.K. experts seek approval for stem cell clinical trial

10/9/2011 | Wall Street Journal, The

Pfizer and scientists at the University College London's Institute of Ophthalmology have asked U.K. regulators to allow them to start a clinical trial of retinal cells, derived from human embryonic stem cells, in patients with age-related macular degeneration. They hope to conduct the U.K. study in 2012.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA